Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spinal Dynamics Corp.

This article was originally published in Start Up

Executive Summary

Spinal Dynamics Corp. hopes that its spinal disc replacement system will simulate the cushioning function of a normal disc, to restore a patient's normal movement and prevent the degeneration of adjacent discs.

You may also be interested in...



Spine Update: BMP Use Continues to Expand

Medtronic recently declared that InFUSE, the company's blockbuster spine bone graft product that provides the growth factor rhBMP-2 as part of a lumbar fusion cage, was well on its way to becoming standard of care in spine surgery. The company's success has fueled interest in a plethora of potential entrants into the biologic bone formation market.

At AAOS, A Debate Over Disc Replacement

In recent years, few technology areas in orthopedics have stimulated more debate than spine, and at the head of the controversy, as evidenced by this year's annual meeeting of the American Academy of Orthopedic Surgeons, is disc replacement.

Spine Arthroplasty's Next Generation

Spine arthroplasty--replacing either the entire disc or simply the nucleus--is one of the most promising new therapies to treat patients with herniated discs and degenerative disc disease. But the technology has had a rocky history: rushed into patients too soon, without proper clinical trials, say critics, disc replacement languished in Europe and took a long time to attract interest in the US. Moreover, first generation arthroplasty products, most notably discs, had several drawbacks that limited adoption--some were very hard to implant, for example, while others were too stiff and tended to extrude. Companies like Disc Dynamics hope to ride the wave of interest in disc and nucleus replacement as it develops new technology that is both superior to first generation products and backed by the proper kinds of clinical studies.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel